saascode
healthcare & clinical·run 53 · May 2026

Wearguard

A managed wearable-data workspace for consented wellness cohorts, separating device observations, aggregate analysis, clinical review and employment authority.

Genesis score6.57/10
Make Wearguard real.0/500
500 more votes and Wearguard is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The case

Hospital occupational-health and corporate wellness teams may want a private way to aggregate employee-authorized wearable data across vendors. The supplied research confirms an open wearable platform with several device integrations and single-organization deployment, while finding no matching managed platform with open algorithms and a business associate agreement.

Wearguard would provision one isolated organization per deployment, manage connectors, preserve participant consent and revocation, normalize device observations and produce cohort aggregates above privacy thresholds. Individual deviation candidates, if permitted at all, would route only to an authorized occupational-health clinician under a defined care or wellness purpose; they would never flow directly to managers, scheduling, discipline, hiring or benefits decisions.

Open code does not make an algorithm valid, fair or defensible under employment law. A business associate agreement is a contract allocation, not proof of HIPAA compliance or even applicability. Wearable data varies by device, wear time and consumer algorithm and is not clinical truth. Employer sponsorship can make consent coercive; alternatives, non-retaliation, labor and accommodation review, purpose limitation and access separation are load-bearing.

The buyer is specific: hospital occupational health or an employer wellness function. A pilot should be voluntary, use aggregate reporting, one organization and a small device set, and include privacy, clinical, employment and worker-representative review before any individual workflow.

Who pays — and why

A hospital occupational-health or employer wellness team running a voluntary program with independent privacy, clinical, employment and worker-representation oversight.

What it unlocks
A participant consent registry preserving program purpose, device authorization, data categories, retention, alternatives, revocation and non-retaliation acknowledgment
An isolated wearable ingestion layer separating vendor observation, device and algorithm version, wear-time quality, normalization, missingness and participant correction
A cohort and review workflow with privacy thresholds, aggregate release approval, individual clinical-review gate and explicit prohibition on employment decisions
How Genesis scored it
6.57across seven criteria
tension 6temporal 8blindspot 5buyer 8leverage 6convergence 5why-not 7
8
Temporal window

The supplied research confirms a recently updated open platform and current employer-wearable legal concern.

8
Buyer persona

Hospital occupational health and employer wellness teams are identifiable, with a concrete private-deployment workflow.

5
Convergence

No cross-references and limited inbound and direct connections leave convergence modest.

Why it scored well

The input confirms an active open wearable foundation, multiple device integrations and a specific hospital occupational-health buyer with a managed-deployment gap.

What's holding it back

Consent coercion, employment law, clinical validity, privacy thresholds, connector operations and no proven structural incumbent barrier make the original defensibility claim unsafe.

Signals detected4 sources crossed
SignalSupplied capability research

SignalSupplied repository research

SignalSupplied market research

SignalSupplied competitor research

Direction briefwearguard.md
wearguard.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.